Edwards Lifesciences Corp. (EW)
107.18
+1.38
(+1.30%)
USD |
NYSE |
Nov 13, 16:00
107.18
0.00 (0.00%)
After-Hours: 19:59
Edwards Lifesciences Enterprise Value : 57.06B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 57.06B |
| November 11, 2026 | 57.06B |
| November 10, 2026 | 56.03B |
| November 09, 2026 | 56.43B |
| November 06, 2026 | 54.95B |
| November 05, 2026 | 54.19B |
| November 04, 2026 | 53.36B |
| November 03, 2026 | 50.95B |
| November 02, 2026 | 49.84B |
| October 30, 2026 | 49.12B |
| October 29, 2026 | 50.52B |
| October 28, 2026 | 48.99B |
| October 27, 2026 | 48.44B |
| October 26, 2026 | 48.29B |
| October 23, 2026 | 47.43B |
| October 22, 2026 | 48.02B |
| October 21, 2026 | 47.04B |
| October 20, 2026 | 46.98B |
| October 19, 2026 | 46.36B |
| October 16, 2026 | 46.01B |
| October 15, 2026 | 46.87B |
| October 14, 2026 | 45.92B |
| October 13, 2026 | 45.24B |
| October 12, 2026 | 45.89B |
| October 09, 2026 | 45.21B |
| Date | Value |
|---|---|
| October 08, 2026 | 44.65B |
| October 07, 2026 | 45.53B |
| October 06, 2026 | 45.94B |
| October 05, 2026 | 46.37B |
| October 02, 2026 | 45.17B |
| October 01, 2026 | 45.19B |
| September 30, 2026 | 45.85B |
| September 29, 2026 | 47.34B |
| September 28, 2026 | 46.62B |
| September 25, 2026 | 46.31B |
| September 24, 2026 | 45.99B |
| September 23, 2026 | 46.62B |
| September 22, 2026 | 47.75B |
| September 21, 2026 | 47.49B |
| September 18, 2026 | 47.45B |
| September 17, 2026 | 47.44B |
| September 16, 2026 | 48.04B |
| September 15, 2026 | 45.99B |
| September 14, 2026 | 45.87B |
| September 11, 2026 | 45.20B |
| September 10, 2026 | 46.59B |
| September 09, 2026 | 46.25B |
| September 08, 2026 | 46.56B |
| September 04, 2026 | 48.39B |
| September 03, 2026 | 48.32B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intuitive Surgical, Inc. | 148.53B |
| Stryker Corp. | 131.09B |
| Abbott Laboratories | 213.21B |
| Boston Scientific Corp. | 75.60B |
| Glaukos Corp. | 14.32B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 301.40M |
| Revenue (Quarterly) | 1.716B |
| Total Expenses (Quarterly) | 1.408B |
| EPS Diluted (Quarterly) | 0.5324 |
| Gross Profit Margin (Quarterly) | 78.37% |
| Profit Margin (Quarterly) | 17.57% |
| Earnings Yield | 1.60% |
| Operating Earnings Yield | 3.12% |
| Normalized Earnings Yield | 2.354 |